PMS2 and neoplasm: Whether the sensitivity of IHC to identify carriers of PMS2-mutations is similar to MSH6 or to the high sensitivity reported for tumours caused by MLH1- or MSH2-mutations cannot be addressed in the present study where carriers of only one mutation were included, but needs further clarification.